前列腺增生症(BPH)是老年男性常见病。尸检发病率在40岁时约23%,至90岁时可达88%。目前对前列腺增生症的治疗有以下方法。一、药物治疗因多数BPH患者伴有心肺脏器疾病,手术及其他侵入性处理有一定危险,故多需药物治疗。1.α受体阻滞剂:增生的前列腺组织和前列腺外科包膜内均富含α肾上腺素能受体,而β受体含量甚微。在体外试验中,前列腺组织对α受体兴奋 Benign prostatic hyperplasia (BPH) is a common disease in elderly men. The autopsy rate is about 23% at age 40 and up to 88% at age 90. The current treatment of benign prostatic hyperplasia has the following methods. First, the drug treatment Most patients with heart disease associated with heart disease, BPH surgery and other invasive treatment have a certain risk, so the need for drug treatment. 1. Alpha blockers: Prostatic hyperplasia and prostate surgical capsule are rich in alpha adrenergic receptors, and beta receptor content was minimal. Prostate tissue is excited by alpha receptors in in vitro experiments